Advertisement

Refractory Hypertension

  • C. Venkata S. Ram
Chapter
Part of the Current Clinical Practice book series (CCP)

Abstract

Because of widespread treatment of systemic hypertension, true refractory hypertension is somewhat unusual in the current management of hypertensive disorders. A majority of patients with uncomplicated primary hypertension respond to one or two drugs. Hypertension is considered refractory if the blood pressure (BP) cannot be reduced below 140/90 mmHg in patients who are compliant with an appropriate triple-drug regimen that includes a diuretic, with all the components prescribed in near maximal or tolerated doses. For patients with isolated systolic hypertension, refractoriness is defined as a failure of an adequate triple-drug regimen to reduce systolic blood pressure below 160 mmHg.

Keywords

Obstructive Sleep Apnea Resistant Hypertension Renovascular Hypertension Target Organ Damage White Coat Hypertension 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Thibonnier M (1992) Ambulatory blood pressure monitoring: when is it warranted? Postgrad Med 91: 263–274.PubMedGoogle Scholar
  2. 2.
    Messerli FH, Ventura HO, Amodeo C (1985) Osler’s maneuver and pseudohypertension. N Engl J Med 312: 1548–1551.PubMedCrossRefGoogle Scholar
  3. 3.
    Mejia AD, Egan BM, Schork NJ, Sweifler (1990) Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension. Ann Intern Med 112: 270–277.Google Scholar
  4. 4.
    Dustan HP, Tarazi RM, Bravo EL (1972) Dependance of arterial pressure on intravascular volume in treated hypertensive patients. N Engl J Med 286: 861–866.PubMedCrossRefGoogle Scholar
  5. 5.
    Bloxham CA, Beevers DG, Walker JM (1979) Malignant hypertension and cigarette smoking. BMJ 1:581–583.Google Scholar
  6. 6.
    Tuomilehto J, Enlund H, Salonen JG, Nissinen A (1984) Alcohol, patient compliance and blood pressure control in hypertensive patients. Scand J Soc Med 12: 177181.Google Scholar
  7. 7.
    Freestone S, Ramsay LE (1983) Frusemide and spironolactone in resistant hypertension: a controlled trial. J Hypertens 1 (Suppl. 2): 326–328.Google Scholar
  8. 8.
    Lewis RV, Toner JM, Jackson PR, Ramsay LE (1986) Effects of indomethacin and sulindac and blood pressure of hypertensive patients. BMJ 292: 934–935.PubMedCrossRefGoogle Scholar
  9. 9.
    Johnson AG, Simons LA, Simons J, Friedlander Y, McCallum J (1993) Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study. Br J Clin Pharmacol 35: 455–459.PubMedCrossRefGoogle Scholar
  10. 10.
    Ying CY, Tiffe CP, Gavros H, et al. (1984) Renal revascularization in the azotemic patient resistant to therapy. N Engl J Med 311: 1070–1075.PubMedCrossRefGoogle Scholar
  11. 11.
    Gifford RW Jr (1998) An Algorhythm for the management of resistant hypertension. Hypertension 11(Suppl. 2):II-101—II-105.Google Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • C. Venkata S. Ram

There are no affiliations available

Personalised recommendations